| Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ... The Lancet Neurology 13 (6), 614-629, 2014 | 3880 | 2014 |
| Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria GU Höglinger, G Respondek, M Stamelou, C Kurz, KA Josephs, AE Lang, ... Movement disorders 32 (6), 853-864, 2017 | 2061 | 2017 |
| Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ... Alzheimer's & Dementia 12 (3), 292-323, 2016 | 2038 | 2016 |
| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1695 | 2015 |
| Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins S Ray, M Britschgi, C Herbert, Y Takeda-Uchimura, A Boxer, K Blennow, ... Nature medicine 13 (11), 1359-1362, 2007 | 1334 | 2007 |
| PET imaging of tau deposition in the aging human brain M Schöll, SN Lockhart, DR Schonhaut, JP O’Neil, M Janabi, ... Neuron 89 (5), 971-982, 2016 | 1242 | 2016 |
| Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease R Ossenkoppele, DR Schonhaut, M Schöll, SN Lockhart, N Ayakta, ... Brain 139 (5), 1551-1567, 2016 | 1159 | 2016 |
| Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s disease J Zhou, MD Greicius, ED Gennatas, ME Growdon, JY Jang, ... Brain 133 (5), 1352-1367, 2010 | 1130 | 2010 |
| Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group B Dubois, N Villain, GB Frisoni, GD Rabinovici, M Sabbagh, S Cappa, ... The Lancet Neurology 20 (6), 484-496, 2021 | 874 | 2021 |
| Episodic memory loss is related to hippocampal-mediated β-amyloid deposition in elderly subjects EC Mormino, JT Kluth, CM Madison, GD Rabinovici, SL Baker, BL Miller, ... Brain 132 (5), 1310-1323, 2009 | 794 | 2009 |
| Seizures and epileptiform activity in the early stages of Alzheimer disease KA Vossel, AJ Beagle, GD Rabinovici, H Shu, SE Lee, G Naasan, ... JAMA neurology 70 (9), 2013 | 758 | 2013 |
| Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease A Bejanin, DR Schonhaut, R La Joie, JH Kramer, SL Baker, N Sosa, ... Brain 140 (12), 3286-3300, 2017 | 742 | 2017 |
| Posterior cortical atrophy SJ Crutch, M Lehmann, JM Schott, GD Rabinovici, MN Rossor, NC Fox The Lancet Neurology 11 (2), 170-178, 2012 | 706 | 2012 |
| Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ... Jama 313 (19), 1939-1950, 2015 | 687 | 2015 |
| Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ... Nature medicine 26 (3), 387-397, 2020 | 658 | 2020 |
| Four distinct trajectories of tau deposition identified in Alzheimer’s disease JW Vogel, AL Young, NP Oxtoby, R Smith, R Ossenkoppele, ... Nature medicine 27 (5), 871-881, 2021 | 608 | 2021 |
| Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management GD Rabinovici, BL Miller CNS drugs 24, 375-398, 2010 | 607 | 2010 |
| Consensus classification of posterior cortical atrophy SJ Crutch, JM Schott, GD Rabinovici, M Murray, JS Snowden, ... Alzheimer's & Dementia 13 (8), 870-884, 2017 | 598 | 2017 |
| Aβ amyloid and glucose metabolism in three variants of primary progressive aphasia GD Rabinovici, WJ Jagust, AJ Furst, JM Ogar, CA Racine, EC Mormino, ... Annals of neurology 64 (4), 388-401, 2008 | 598 | 2008 |
| The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features R Ossenkoppele, YAL Pijnenburg, DC Perry, BI Cohn-Sheehy, ... Brain 138 (9), 2732-2749, 2015 | 587 | 2015 |
